467 related articles for article (PubMed ID: 16103706)
1. Leukocytoclastic vasculitis: a rare manifestation of propylthiouracil hypersensitivity.
Erem C; Yucel Y; Ya Z; Reis A; Kocak M; Hacihasanoglu A
Med Princ Pract; 2005; 14(5):366-9. PubMed ID: 16103706
[TBL] [Abstract][Full Text] [Related]
2. Propylthiouracil-induced cutaneous vasculitis.
Yarman S; Sandalci O; Tanakol R; Azizlerli H; Oguz H; Alagöl F
Int J Clin Pharmacol Ther; 1997 Jul; 35(7):282-6. PubMed ID: 9247841
[TBL] [Abstract][Full Text] [Related]
3. Leukocytoclastic vasculitis: a rare manifestation of propylthiouracil allergy.
Casis FC; Perez JB
Endocr Pract; 2000; 6(4):329-32. PubMed ID: 11242611
[TBL] [Abstract][Full Text] [Related]
4. Necrotizing vasculitis in a patient affected by autoimmune hyperthyroidism treated with propylthiouracil.
Antonucci A; Bardazzi F; Iozzo I; Patrizi A
Dermatol Ther; 2010; 23 Suppl 2():S41-3. PubMed ID: 20482568
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic antibody-positive cutaneous leukocytoclastic vasculitis associated with propylthiouracil therapy.
Sheen YS; Chu CY; Yu HS
Arch Dermatol; 2006 Jul; 142(7):879-80. PubMed ID: 16847204
[No Abstract] [Full Text] [Related]
6. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous vasculitis associated with propylthiouracil therapy.
Carrasco MD; Riera C; Clotet B; Grifol M; Foz M
Arch Intern Med; 1987 Sep; 147(9):1677. PubMed ID: 3632175
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.
Morais P; Baudrier T; Mota A; Cunha AP; Alves M; Neves C; Capela J; Sá-Couto P; Azevedo F
Cutan Ocul Toxicol; 2011 Jun; 30(2):147-53. PubMed ID: 21091384
[TBL] [Abstract][Full Text] [Related]
9. [Leukocytoclastic vasculitis as an adverse effect of propylthiouracil. A case report].
Cortés-Guzmán JS; Veloza KT; Domínguez JD; Pinzón-Tovar A
Rev Alerg Mex; 2023 May; 70(1):51-54. PubMed ID: 37566757
[TBL] [Abstract][Full Text] [Related]
10. [Anti neutrophil cytoplasmatic antibodies-positive vasculitis as a complication of hyperthyreosis treatment with propylthiouracil].
Wiśniewski P; Lewczuk A; Czaplińska-Kałas H; Porzezińska M; Sworczak K
Pol Merkur Lekarski; 2005 Nov; 19(113):674-7. PubMed ID: 16498810
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic antibody associated vasculitis and rapidly progressive glomerulonephritis as a complication of propylthiouracil therapy.
Erten Y; Bodur H; Sahiner S; Tolunay O; Akkaya V; Canbakan B; Bali M
Clin Endocrinol (Oxf); 2002 Nov; 57(5):699-700. PubMed ID: 12390348
[No Abstract] [Full Text] [Related]
12. Propylthiouracil-induced hypersensitivity syndrome.
Aycan Z; Arhan E; Cetinkaya E; Vidinlisan S; Menekşe N; Yücel H; Cakar N
Turk J Pediatr; 2006; 48(2):162-5. PubMed ID: 16848120
[TBL] [Abstract][Full Text] [Related]
13. [Necrotizing vasculitis as a manifestation of hypersensitivity to propylthiouracil].
Dinato SL; Dinato MC; Dinato MM; Ribeiro MC; Yamashiro CY; Romiti N
Arq Bras Endocrinol Metabol; 2009 Apr; 53(3):374-7. PubMed ID: 19578601
[TBL] [Abstract][Full Text] [Related]
14. Recurrent episodes of arthritis in a hyperthyroid patient.
Tan F; Nam TQ; Lee KO; Cheah WK; Mukherjee JJ
Singapore Med J; 2006 Feb; 47(2):163-5. PubMed ID: 16435062
[TBL] [Abstract][Full Text] [Related]
15. Nodular vasculitis associated with propylthiouracil therapy.
Wolf D; Ben-Yehuda A; Okon E; Naparstek Y
Cutis; 1992 Apr; 49(4):253-5. PubMed ID: 1521477
[TBL] [Abstract][Full Text] [Related]
16. Anti-neutrophil cytoplasmic antibody-associated mucocutaneous allergic vasculitis with oral manifestations caused by propylthiouracil.
Sorribes MM; Welinder NR; Stangerup SE
J Laryngol Otol; 1999 May; 113(5):477-9. PubMed ID: 10505168
[TBL] [Abstract][Full Text] [Related]
17. Antineutrophil cytoplasmic antibody-positive vasculitis in a patient with graves disease: cross-reaction between propylthiouracil and methimazole.
Ahmed K; Rao S; Simha V
Endocr Pract; 2010; 16(3):449-51. PubMed ID: 20061292
[TBL] [Abstract][Full Text] [Related]
18. Propylthiouracil hypersensitivity: report of two patients with vasculitis and review of the literature.
Chastain MA; Russo GG; Boh EE; Chastain JB; Falabella A; Millikan LE
J Am Acad Dermatol; 1999 Nov; 41(5 Pt 1):757-64. PubMed ID: 10534640
[TBL] [Abstract][Full Text] [Related]
19. [Pericarditis and vasculitis secondary to the administration of propylthiouracil].
Gleisner A; Wilhelm V
Rev Chil Pediatr; 1986; 57(1):64-6. PubMed ID: 3763985
[No Abstract] [Full Text] [Related]
20. Clinical and laboratory characteristics of drug-induced vasculitic syndromes.
Wiik A
Arthritis Res Ther; 2005; 7(5):191-2. PubMed ID: 16207347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
